A severe case of neuro-Sjögren’s syndrome induced by pembrolizumab

BACKGROUND: The prevalence of connective tissue disease (CTD) induced by immune checkpoint inhibitors (CPIs) in the absence of pre-existing autoimmunity is unknown. CASE PRESENTATION: We report the case of a melanoma patient treated for 8 months with pembrolizumab who developed a subacute ataxic sen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosn, Jaqueline, Vicino, Alex, Michielin, Olivier, Coukos, George, Kuntzer, Thierry, Obeid, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196470/
https://www.ncbi.nlm.nih.gov/pubmed/30348223
http://dx.doi.org/10.1186/s40425-018-0429-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196470/
https://www.ncbi.nlm.nih.gov/pubmed/30348223
http://dx.doi.org/10.1186/s40425-018-0429-4

Ejemplares similares